Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02076581 · ClinicalTrials.gov registry record
MyoSense- Automated Muscle Hypertonicity Classification System
A clinical trial, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- 53
- Enrollment target
NCT02076581 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 53 participants.
The verdict
NCT02076581 has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
It is often difficult to quantify and distinguish aspects of abnormal muscle tone due to neurological injury. This makes it difficult to evaluate therapies that aim to reduce the effects of abnormal muscle tone. This research study will evaluate the feasibility of a clinician worn device to capture and quantify features of spasticity and dystonia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02076581
The ClinicalTrials.gov registry entry for NCT02076581 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Great Lakes NeuroTechnologies, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02076581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02076581 about?
NCT02076581 is a clinical study titled "MyoSense- Automated Muscle Hypertonicity Classification System". It is often difficult to quantify and distinguish aspects of abnormal muscle tone due to neurological injury. This makes it difficult to evaluate therapies that aim to reduce the effects of abnormal muscle tone. This research study will evaluate the feasibility of a clinician worn device to capture ...
What is the current status of trial NCT02076581?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2014-02. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT02076581?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.